Detalhe da pesquisa
1.
Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada.
J Comp Eff Res
; 12(9): e220175, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37606897
2.
Characterization of a novel disease-associated mutation within NPHS1 and its effects on nephrin phosphorylation and signaling.
PLoS One
; 13(9): e0203905, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30212551